153 related articles for article (PubMed ID: 5554814)
1. [C1-inactivator from guinea pig-serum mechanism of action. II. Effect of the inactivator on C1 in its bound form: EAC1, EAC14b and EAC14b2a].
Loos M
Z Med Mikrobiol Immunol; 1971; 156(2):221-32. PubMed ID: 5554814
[No Abstract] [Full Text] [Related]
2. [C1-inactivator from guinea pig serum-mechanism of action. I. Effect of the inactivator on C1 in free solution].
Loos M; Opferkuch W; Wagner H
Z Med Mikrobiol Immunol; 1971; 156(2):208-20. PubMed ID: 4995250
[No Abstract] [Full Text] [Related]
3. [The C1-inactivator of guinea pig serum: titration, purification and characterization of the inactivator].
Opferkuch W; Loos M; Ringelmann R
Z Med Mikrobiol Immunol; 1971; 156(2):194-207. PubMed ID: 4995249
[No Abstract] [Full Text] [Related]
4. An anticomplementary agent, K-76 monocarboxylic acid: its site and mechanism of inhibition of the complement activation cascade.
Hong K; Kinoshita T; Miyazaki W; Izawa T; Inoue K
J Immunol; 1979 Jun; 122(6):2418-23. PubMed ID: 448130
[TBL] [Abstract][Full Text] [Related]
5. Specific inactivation of the fourth complement component. II. In vitro studies.
Garces MC; Jensen JA; Iglesias E
Infect Immun; 1971 Oct; 4(4):446-51. PubMed ID: 5154891
[TBL] [Abstract][Full Text] [Related]
6. The fifth component of the guinea pig complement system. II. Mechanism of SAC1,4,2,3,5b formation and C5 consumption by EAC1,4,2,3.
Shin HS; Pickering RJ; Mayer MM
J Immunol; 1971 Feb; 106(2):473-9. PubMed ID: 5545153
[No Abstract] [Full Text] [Related]
7. Inhibition of the lytic effect of guinea pig complement by rabbit complement.
Kempf RA; Gigli I; Austen KF
J Immunol; 1969 Apr; 102(4):795-803. PubMed ID: 5768190
[No Abstract] [Full Text] [Related]
8. C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.
Ruddy S; Austen KF
J Immunol; 1969 Mar; 102(3):533-43. PubMed ID: 5813010
[No Abstract] [Full Text] [Related]
9. A monoclonal antibody that blocks the complement regulatory activity of guinea pig erythrocytes and characterization of the antigen involved as guinea pig decay-accelerating factor.
Okada N; Tanaka H; Takizawa H; Okada H
J Immunol; 1995 Jun; 154(11):6103-11. PubMed ID: 7538542
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of complement-induced cell lysis. Demonstration of a three-step mechanism of EAC1-8 cell lysis by C9 and of a non-osmotic swelling of erythrocytes.
Valet G; Opferkuch W
J Immunol; 1975 Oct; 115(4):1028-33. PubMed ID: 809505
[TBL] [Abstract][Full Text] [Related]
11. The Cl inactivator from guinea pig serum. 3. Characterization and kinetic data of the reaction between the inactivator and EACl and EACl4.
Loos M; Wolf HU; Opferkuch W
Immunochemistry; 1972 Apr; 9(4):451-9. PubMed ID: 4113723
[No Abstract] [Full Text] [Related]
12. Complement inhibitor(s) released by leukocytes. III. Evidence for a "new" C1 inhibitor in the supernatants of short-term cultures of mouse spleen and thymus cells.
Bernard A; Boumsell L; Borsos
J Immunol; 1975 Oct; 115(4):1091-4. PubMed ID: 1176767
[TBL] [Abstract][Full Text] [Related]
13. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
May JE; Frank MM
J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
[No Abstract] [Full Text] [Related]
14. Activation of the first component of complement evidence for an internal activation step.
Loos M; Borsos T; Rapp HJ
J Immunol; 1972 Mar; 108(3):683-8. PubMed ID: 5011751
[No Abstract] [Full Text] [Related]
15. Inactivation of C1 in rheumatoid synovial fluid, purfied C1 and C1 esterase, by gold compounds.
Schultz DR; Volanakis JE; Arnold PI; Gottlieb NL; Sakai K; Stroud RM
Clin Exp Immunol; 1974 Jul; 17(3):395-406. PubMed ID: 4219842
[TBL] [Abstract][Full Text] [Related]
16. Antigenic relationship between the C4 inactivating substance produced by KB cell cultures and the first component of human complement (C1).
Füst G; Kósa S
Med Microbiol Immunol; 1972; 157(3):244-50. PubMed ID: 4625764
[No Abstract] [Full Text] [Related]
17. Inhibition of guinea-pig complement by derivatives of benzamidine. I. Effect of p-nitrophenylureido derivative of m-(m-phenoxypropoxy)benzamidine on guinea-pig complement component haemolytic activity.
Glovsky MM; Cory M; Alenty A
Immunology; 1974 Apr; 26(4):819-29. PubMed ID: 4136824
[TBL] [Abstract][Full Text] [Related]
18. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
Houle JJ; Hoffmann EM
J Immunol; 1984 Sep; 133(3):1444-52. PubMed ID: 6430999
[TBL] [Abstract][Full Text] [Related]
19. Studies of guinea pig complement component C9: reaction kinetics and evidence that lysis of EAC1-8 results from a single membrane lesion caused by one molecule of C9.
Rommel FA; Mayer MM
J Immunol; 1973 Mar; 110(3):637-47. PubMed ID: 4688916
[No Abstract] [Full Text] [Related]
20. Automation of immune hemolytic and complement reactions by AutoAnalyzer. II.
Vargues R; Henley W
Mt Sinai J Med; 1974; 41(3):453-79. PubMed ID: 4134099
[No Abstract] [Full Text] [Related]
[Next] [New Search]
